Form D · Biotechnology
OPTIMA NEUROSCIENCE INC
Alachua, FL · CIK 0001427988
Offering snapshot reported Jul 8, 2010 · SEC filing
- Reported sold
- $265K Offering amount: $300K
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $30K Reported outside-investor minimum
- First sale
- Feb 12, 2010 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
- Reported investors0 → 5
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 8, 2010 | Amendment | $265,299 | No comparison | 5 | SEC filing |
| Feb 19, 2010 | Amendment | Yet to sell | No comparison | 0 | SEC filing |
| Sep 2, 2009 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| Feb 19, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-115090
Source: Form D, filed Jul 8, 2010. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Richard R. Allen | Director |
| Amanda M. Burks | Executive, Promoter |
| Ryan T. Kern | Executive, Promoter |
| Jon M. Kurtz | Director |
| J. Chris Sackellares | Director, Executive |
| Deng Shan Shiau | Executive |
| Mark Tanner | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
13420 Progress Boulevard Suite 200
Alachua, FL, 32615
Alachua, FL, 32615